AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GS4071, A POTENT INHIBITOR OF INFLUENZA NEURAMINIDASE, IN PLASMA BY PRECOLUMN FLUORESCENCE DERIVATIZATION WITH NAPHTHALENEDIALDEHYDE
Authors: EISENBERG EJ CUNDY KC
Citation: Ej. Eisenberg et Kc. Cundy, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GS4071, A POTENT INHIBITOR OF INFLUENZA NEURAMINIDASE, IN PLASMA BY PRECOLUMN FLUORESCENCE DERIVATIZATION WITH NAPHTHALENEDIALDEHYDE, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 267-273
EFFECT OF ORAL PROBENECID COADMINISTRATION ON THE CHRONIC TOXICITY AND PHARMACOKINETICS OF INTRAVENOUS CIDOFOVIR IN CYNOMOLGUS MONKEYS
Authors: LACY SA HITCHCOCK MJM LEE WA TELLIER P CUNDY KC
Citation: Sa. Lacy et al., EFFECT OF ORAL PROBENECID COADMINISTRATION ON THE CHRONIC TOXICITY AND PHARMACOKINETICS OF INTRAVENOUS CIDOFOVIR IN CYNOMOLGUS MONKEYS, TOXICOLOGICAL SCIENCES, 44(2), 1998, pp. 97-106
INTRAVITREAL AND PLASMA CIDOFOVIR CONCENTRATIONS AFTER INTRAVITREAL AND INTRAVENOUS ADMINISTRATION IN AIDS PATIENTS WITH CYTOMEGALOVIRUS RETINITIS
Authors: TASKINTUNA I RAHHAL FM CAPPARELLI EV CUNDY KC FREEMAN WR
Citation: I. Taskintuna et al., INTRAVITREAL AND PLASMA CIDOFOVIR CONCENTRATIONS AFTER INTRAVITREAL AND INTRAVENOUS ADMINISTRATION IN AIDS PATIENTS WITH CYTOMEGALOVIRUS RETINITIS, Journal of ocular pharmacology and therapeutics, 14(2), 1998, pp. 147-151
ADMINISTRATION OF 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) FOR PREVENTION OF PERINATAL SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS MACAQUES
Authors: VANROMPAY KKA MARTHAS ML LIFSON JD BERARDI CJ VASQUEZ GM AGATEP E DEHQANZADA ZA CUNDY KC BISCHOFBERGER N PEDERSEN NC
Citation: Kka. Vanrompay et al., ADMINISTRATION OF 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) FOR PREVENTION OF PERINATAL SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS MACAQUES, AIDS research and human retroviruses, 14(9), 1998, pp. 761-773
ISOLATION AND IDENTIFICATION OF A METABOLITE OF CIDOFOVIR FROM RAT-KIDNEY
Authors: EISENBERG EJ LYNCH GR BIDGOOD AM KRISHNAMURTY K CUNDY KC
Citation: Ej. Eisenberg et al., ISOLATION AND IDENTIFICATION OF A METABOLITE OF CIDOFOVIR FROM RAT-KIDNEY, Journal of pharmaceutical and biomedical analysis, 16(8), 1998, pp. 1349-1356
SAFETY, PHARMACOKINETICS, AND ANTIRETROVIRAL ACTIVITY OF INTRAVENOUS 9-[2-(R)-(PHOSPHONOMETHOXY)PROPYL]ADENINE A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS
Authors: DEEKS SG BARDITCHCROVO P LIETMAN PS HWANG F CUNDY KC ROONEY JF HELLMANN NS SAFRIN S KAHN JO
Citation: Sg. Deeks et al., SAFETY, PHARMACOKINETICS, AND ANTIRETROVIRAL ACTIVITY OF INTRAVENOUS 9-[2-(R)-(PHOSPHONOMETHOXY)PROPYL]ADENINE A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2380-2384
IDENTIFICATION OF GS-4104 AS AN ORALLY BIOAVAILABLE PRODRUG OF THE INFLUENZA-VIRUS NEURAMINIDASE INHIBITOR GS-4071
Authors: LI WX ESCARPE PA EISENBERG EJ CUNDY KC SWEET C JAKEMAN KJ MERSON J LEW W WILLIAMS M ZHANG LJ KIM CU BISCHOFBERGER N CHEN MS MENDEL DB
Citation: Wx. Li et al., IDENTIFICATION OF GS-4104 AS AN ORALLY BIOAVAILABLE PRODRUG OF THE INFLUENZA-VIRUS NEURAMINIDASE INHIBITOR GS-4071, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 647-653
PHARMACOKINETICS AND BIOAVAILABILITY OF THE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS NUCLEOTIDE ANALOG 9-[(R)-2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) IN DOGS
Authors: CUNDY KC SUEOKA C LYNCH GR GRIFFIN L LEE WA SHAW JP
Citation: Kc. Cundy et al., PHARMACOKINETICS AND BIOAVAILABILITY OF THE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS NUCLEOTIDE ANALOG 9-[(R)-2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) IN DOGS, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 687-690
SYNTHESIS, IN-VITRO BIOLOGICAL EVALUATION AND ORAL BIOAVAILABILITY OF9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) PRODRUGS
Authors: ARIMILLI MN KIM CU DOUGHERTY J MULATO A OLIYAI R SHAW JP CUNDY KC BISCHOFBERGER N
Citation: Mn. Arimilli et al., SYNTHESIS, IN-VITRO BIOLOGICAL EVALUATION AND ORAL BIOAVAILABILITY OF9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) PRODRUGS, Antiviral chemistry & chemotherapy, 8(6), 1997, pp. 557-564
METABOLISM AND PHARMACOKINETICS OF NOVEL ORAL PRODRUGS OF 9-[(R)-2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) IN DOGS
Authors: SHAW JP SUEOKA CM OLIYAI R LEE WA ARIMILLI MN KIM CU CUNDY KC
Citation: Jp. Shaw et al., METABOLISM AND PHARMACOKINETICS OF NOVEL ORAL PRODRUGS OF 9-[(R)-2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) IN DOGS, Pharmaceutical research, 14(12), 1997, pp. 1824-1829
BIOAVAILABILITY AND METABOLISM OF CIDOFOVIR FOLLOWING TOPICAL ADMINISTRATION TO RABBITS
Authors: CUNDY KC LYNCH G LEE WA
Citation: Kc. Cundy et al., BIOAVAILABILITY AND METABOLISM OF CIDOFOVIR FOLLOWING TOPICAL ADMINISTRATION TO RABBITS, Antiviral research, 35(2), 1997, pp. 113-122
PHARMACOKINETICS AND METABOLISM OF SELECTED PRODRUGS OF PMEA IN RATS
Authors: SHAW JP LOUIE MS KRISHNAMURTHY VV ARIMILLI MN JONES RJ BIDGOOD AM LEE WA CUNDY KC
Citation: Jp. Shaw et al., PHARMACOKINETICS AND METABOLISM OF SELECTED PRODRUGS OF PMEA IN RATS, Drug metabolism and disposition, 25(3), 1997, pp. 362-366
PENETRATION OF GS4071, A NOVEL INFLUENZA NEURAMINIDASE INHIBITOR, INTO RAT BRONCHOALVEOLAR LINING FLUID FOLLOWING ORAL-ADMINISTRATION OF THE PRODRUG GS4104
Authors: EISENBERG EJ BIDGOOD A CUNDY KC
Citation: Ej. Eisenberg et al., PENETRATION OF GS4071, A NOVEL INFLUENZA NEURAMINIDASE INHIBITOR, INTO RAT BRONCHOALVEOLAR LINING FLUID FOLLOWING ORAL-ADMINISTRATION OF THE PRODRUG GS4104, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1949-1952
ORAL FORMULATIONS OF ADEFOVIR DIPIVOXIL - IN-VITRO DISSOLUTION AND IN-VIVO BIOAVAILABILITY IN DOGS
Authors: CUNDY KC SUE IL VISOR GC MARSHBURN J NAKAMURA C LEE WA SHAW JP
Citation: Kc. Cundy et al., ORAL FORMULATIONS OF ADEFOVIR DIPIVOXIL - IN-VITRO DISSOLUTION AND IN-VIVO BIOAVAILABILITY IN DOGS, Journal of pharmaceutical sciences, 86(12), 1997, pp. 1334-1338
ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS
Authors: BARDITCHCROVO P TOOLE J HENDRIX CW CUNDY KC EBELING D JAFFE HS LIETMAN PS
Citation: P. Barditchcrovo et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS, The Journal of infectious diseases, 176(2), 1997, pp. 406-413
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF CYTOSINE-CONTAINING COMPOUNDS BY PRECOLUMN FLUORESCENCE DERIVATIZATION WITH PHENACYL BROMIDE - APPLICATION TO ANTIVIRAL NUCLEOSIDES AND NUCLEOTIDES
Authors: EISENBERG EJ CUNDY KC
Citation: Ej. Eisenberg et Kc. Cundy, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF CYTOSINE-CONTAINING COMPOUNDS BY PRECOLUMN FLUORESCENCE DERIVATIZATION WITH PHENACYL BROMIDE - APPLICATION TO ANTIVIRAL NUCLEOSIDES AND NUCLEOTIDES, Journal of chromatography B. Biomedical applications, 679(1-2), 1996, pp. 119-127
DISTRIBUTION AND METABOLISM OF INTRAVITREAL CIDOFOVIR AND CYCLIC HPMPC IN RABBITS
Authors: CUNDY KC LYNCH G SHAW JP HITCHCOCK MJM LEE WA
Citation: Kc. Cundy et al., DISTRIBUTION AND METABOLISM OF INTRAVITREAL CIDOFOVIR AND CYCLIC HPMPC IN RABBITS, Current eye research, 15(5), 1996, pp. 569-576
PHARMACOKINETICS, SAFETY AND BIOAVAILABILITY OF HPMPC (CIDOFOVIR) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED SUBJECTS
Authors: WACHSMAN M PETTY BG CUNDY KC JAFFE HS FISHER PE PASTELAK A LIETMAN PS
Citation: M. Wachsman et al., PHARMACOKINETICS, SAFETY AND BIOAVAILABILITY OF HPMPC (CIDOFOVIR) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED SUBJECTS, Antiviral research, 29(2-3), 1996, pp. 153-161
DISTRIBUTION AND METABOLISM OF INTRAVITREAL CIDOFOVIR AND CYCLIC HPMPC IN RABBITS
Authors: LEE WA LYNCH G SHAW JP HITCHCOCK MJ CUNDY KC
Citation: Wa. Lee et al., DISTRIBUTION AND METABOLISM OF INTRAVITREAL CIDOFOVIR AND CYCLIC HPMPC IN RABBITS, Investigative ophthalmology & visual science, 37(3), 1996, pp. 2679-2679
PHARMACOKINETICS OF CIDOFOVIR IN MONKEYS - EVIDENCE FOR A PROLONGED ELIMINATION PHASE REPRESENTING PHOSPHORYLATED DRUG
Authors: CUNDY KC LI ZH HITCHCOCK MJM LEE WA
Citation: Kc. Cundy et al., PHARMACOKINETICS OF CIDOFOVIR IN MONKEYS - EVIDENCE FOR A PROLONGED ELIMINATION PHASE REPRESENTING PHOSPHORYLATED DRUG, Drug metabolism and disposition, 24(7), 1996, pp. 738-744
PHARMACOKINETICS, BIOAVAILABILITY, METABOLISM, AND TISSUE DISTRIBUTION OF CIDOFOVIR (HPMPC) AND CYCLIC HPMPC IN RATS
Authors: CUNDY KC BIDGOOD AM LYNCH G SHAW JP GRIFFIN L LEE WA
Citation: Kc. Cundy et al., PHARMACOKINETICS, BIOAVAILABILITY, METABOLISM, AND TISSUE DISTRIBUTION OF CIDOFOVIR (HPMPC) AND CYCLIC HPMPC IN RATS, Drug metabolism and disposition, 24(7), 1996, pp. 745-752
EFFECT OF PROBENECID ON THE DISTRIBUTION, METABOLISM, AND EXCRETION OF CIDOFOVIR IN RABBITS
Authors: CUNDY KC LI ZH LEE WA
Citation: Kc. Cundy et al., EFFECT OF PROBENECID ON THE DISTRIBUTION, METABOLISM, AND EXCRETION OF CIDOFOVIR IN RABBITS, Drug metabolism and disposition, 24(3), 1996, pp. 315-321
NEW SERIES OF POTENT, ORALLY BIOAVAILABLE, NONPEPTIDIC CYCLIC SULFONES AS HIV-1 PROTEASE INHIBITORS
Authors: KIM CU MCGEE LR KRAWCZYK SH HARWOOD E HARADA Y SWAMINATHAN S BISCHOFBERGER N CHEN MS CHERRINGTON JM XIONG SF GRIFFIN L CUNDY KC LEE A YU B GULNIK S ERICKSON JW
Citation: Cu. Kim et al., NEW SERIES OF POTENT, ORALLY BIOAVAILABLE, NONPEPTIDIC CYCLIC SULFONES AS HIV-1 PROTEASE INHIBITORS, Journal of medicinal chemistry, 39(18), 1996, pp. 3431-3434
THE DESIGN OF POTENT AND STABLE BENZISOTHIAZOLONE INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE
Authors: HLASTA DJ BELL MR COURT JJ CUNDY KC DESAI RC FERGUSON EW GORDON RJ KUMAR V MAYCOCK AL SUBRAMANYAM C
Citation: Dj. Hlasta et al., THE DESIGN OF POTENT AND STABLE BENZISOTHIAZOLONE INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE, Bioorganic & medicinal chemistry letters, 5(4), 1995, pp. 331-336
A NOVEL OLIGODEOXYNUCLEOTIDE INHIBITOR OF THROMBIN .1. IN-VITRO METABOLIC STABILITY IN PLASMA AND SERUM
Authors: SHAW JP FISHBACK JA CUNDY KC LEE WA
Citation: Jp. Shaw et al., A NOVEL OLIGODEOXYNUCLEOTIDE INHIBITOR OF THROMBIN .1. IN-VITRO METABOLIC STABILITY IN PLASMA AND SERUM, Pharmaceutical research, 12(12), 1995, pp. 1937-1942
Risultati: 1-25 | 26-33